Back
Keros Therapeutics, Inc. Stock Price Chart
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.
Buy
58
KROS
Keros Therapeutics, Inc.
Last Price:
$19.19
Seasonality Move:
4.66%
7 Day Trial
ALL ACCESS PASS
$
7
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets-
The current trend is relatively stagnant and KROS is experiencing slight buying pressure.
Keros Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.12 | Buy |
| 20-day SMA: | 19.57 | Sell |
| 50-day SMA: | 19.1 | Buy |
| 200-day SMA: | 15.6 | Buy |
| 8-day EMA: | 19.11 | Buy |
| 20-day EMA: | 19.33 | Buy |
| 50-day EMA: | 18.83 | Buy |
| 200-day EMA: | 18.82 | Buy |
Keros Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 51.64 | Buy |
| Chaikin Money Flow: | 114201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Keros Therapeutics, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics, Inc. Stock
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 19.46 while KROS 8-day simple moving average is 19.12, which is a Buy signal.
-
The stock price of KROS is 19.46 while Keros Therapeutics, Inc. 20-day SMA is 19.57, which makes it a Sell.
-
Keros Therapeutics, Inc. 50-day simple moving average is 19.10 while KROS share price is 19.46, making it a Buy technically.
-
KROS stock price is 19.46 and Keros Therapeutics, Inc. 200-day simple moving average is 15.60, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Buy
58
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy or a Sell?
-
Keros Therapeutics, Inc. stock is rated a BuyThe current Keros Therapeutics, Inc. [KROS] share price is $19.46. The Score for KROS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Keros Therapeutics, Inc. Stock Info
Market Cap:
596.5M
Price in USD:
19.46
Share Volume:
285.5K
Keros Therapeutics, Inc. 52-Week Range
52-Week High:
22.55
52-Week Low:
9.12
Buy
58
Keros Therapeutics, Inc. (KROS)
is a Buy
Keros Therapeutics, Inc. Share Price Forecast
-
What is the Keros Therapeutics, Inc. stock price today?The Keros Therapeutics, Inc. stock price is 19.46 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics, Inc. is not overvalued.
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 19.46 while KROS 8-day exponential moving average is 19.11, which is a Buy signal.
-
The stock price of KROS is 19.46 while Keros Therapeutics, Inc. 20-day EMA is 19.33, which makes it a Buy.
-
Keros Therapeutics, Inc. 50-day exponential moving average is 18.83 while KROS share price is 19.46, making it a Buy technically.
-
KROS stock price is 19.46 and Keros Therapeutics, Inc. 200-day simple moving average is 18.82, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics, Inc.
Is Keros Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.27 per share, and a decrease next year of $0.80 per share.
Technical Analysis of Keros Therapeutics, Inc.
Should I short Keros Therapeutics, Inc. stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Keros Therapeutics, Inc. is a Sell
-
Keros Therapeutics, Inc. Relative Strength Index (RSI) is 51.64, which suggest Keros Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Keros Therapeutics, Inc. is ( - ), which suggest Keros Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Keros Therapeutics, Inc. is ( - ), which suggest Keros Therapeutics, Inc. is a Buy
* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.